Noam Ohana
Angel Investor @ EXOR N.V.
New York, United States
Noam Ohana is a Managing Director at Exor Prior to managing Exor Seeds, Noam was managing partner of Conegliano Ventures, a venture capital fund. Noam was also Partner of BeaconLight Capital, a global equity long-short fund he co-founded in 2010. Noam started his investment career in 2007 at Atticus Capital, where he managed a fund-of-funds. Noamgraduated from Sciences Po (Public Affairs) in 1999 and from Stanford University (MA), where he was a Fulbright Scholar, in 2001.
- Total investments:
- 36
- Last investment:
- Lead investor:
- 58%
Last updated:
For AI agents: llms.txt
Industries Noam Ohana invests in
Stages Noam Ohana invests in
Countries Noam Ohana invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 3 (8%)
- Transportation 3 (8%)
- Health Care 2 (6%)
- Ride Sharing 2 (6%)
- Electric Vehicle 2 (6%)
Stage
- Seed 6 (17%)
- Series A 4 (11%)
- Pre-Seed 2 (6%)
- Series C 2 (6%)
- Venture - Series Unknown 2 (6%)
Country
- United States 4 (11%)
- Italy 2 (6%)
- France 2 (6%)
- United Kingdom 2 (6%)
- Spain 1 (3%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Tenna Systems develops a platform that supports real-time monitoring, geolocation, and mitigation of radio-frequency interference to help maintain dependable connectivity for mission-critical systems. Its technology is informed by extensive experience in electromagnetic warfare and is designed to enhance awareness of RF activity across complexoperational environments. Tip&Cue supports defense, aerospace, and mobility organizations by enabling detection and analysis of interference sources and by strengthening the resilience of systems that depend on spectrum availability. | $13.5M / Seed / Feb 08, 2026 | ||
| PhaseV is creating tools and cutting-edge statistical approaches to transform trial design, execution, and analysis. PhaseV recognizes hidden signals in clinical data and extracts actionable insights to help determine the best next moves. The company's technology provides optimal adaptive clinical trial design and closed-loop execution,enhancing efficiency and success rates. PhaseV is developing clinical trial paradigm shifts in order to provide novel therapies to more people in a more precise and efficient manner. | $50M / Series A / May 13, 2025 | ||
| InBolt has developed the world’s smallest and most efficient 3D camera tracking system. Their first product is a hardware module / device that an operator can plug onto all manual tools such as a drill, a screwdriver or a torque wrench. Once on the tool, it guides the operator, validates the completion of a task in real time and registers allthe completion parameters. | $16.7M / Series A / Sep 19, 2024 | ||
| Cowboy is an e-bike company that creates innovative electric bikes for city riders. It is still transforming the bike and mobility industries, from the point of sale to the point of service. Its mission is to empower riders to map their own paths, as well as the paths of the cities in which they live, through mindful movement that benefitseveryone.Cowboy's electric bikes are simple — there is no gear and no + and - buttons to adjust the motor's power. The company believes riding a bike should be as simple as hopping into the saddle and putting one foot on the peddle. | $4.4M / Venture - Series Unknown / Sep 04, 2024 | ||
| All the health information we need is within us. Just below the skin. SAVA is redefining the way people interact with their health by developing the most advanced biosensing technology science has to offer, capable of accessing bodily information in a painless, real-time and affordable way. | $8M / Seed / Jun 21, 2024 | ||
| Find buyers. Hit sales numbers! | $9.9M / Seed / Jun 11, 2024 | ||
| Jigsaw builds diagrams, allowing users to both visualize and manipulate the complex underlying data. | $15.1M / Series A / Apr 29, 2024 | ||
| PhaseV is creating tools and cutting-edge statistical approaches to transform trial design, execution, and analysis. PhaseV recognizes hidden signals in clinical data and extracts actionable insights to help determine the best next moves. The company's technology provides optimal adaptive clinical trial design and closed-loop execution,enhancing efficiency and success rates. PhaseV is developing clinical trial paradigm shifts in order to provide novel therapies to more people in a more precise and efficient manner. | $15M / Seed / Oct 24, 2023 | ||
| Via is a re-engineering public transit company that develops and provides on-demand public mobility solutions for commuters. The company transforms public transit from a regulated system of rigid routes and schedules to a fully dynamic, on-demand network. Via's mobile app connects passengers who are headed the same way, allowing riders toseamlessly share a premium vehicle. The platform operates in the United States and in Europe through its joint venture with Mercedes-Benz Vans, ViaVan. Via's technology is deployed worldwide through partner projects with public transportation agencies, private transit operators, taxi fleets, private companies, and universities, integrating with public transit infrastructure to power cutting-edge on-demand mobility.Via's software offers an end-to-end solution for planning, optimizing, and operating efficient and equitable transit systems, thereby unlocking opportunity for all and constructing resilient cities for the future. | $110M / Venture - Series Unknown / Feb 13, 2023 | ||
| Eoliann harnesses satellite data and proprietary machine learning algorithms to predict the probability, intensity, and potential impact of extreme climate events. The solutions empower critical infrastructure operators to design robust resilience strategies and simplify ESG risk disclosure. | $1.6M / Pre-Seed / Nov 23, 2022 | ||
| See all 36 investments → | |||
Co-Investors
About EXOR N.V.
EXOR is a holding company based in the Netherlands that the Agnelli family controls. The company has a diverse portfolio of investments in various industries, including automotive, real estate, and finance. The company is known for taking a long-term approach to its assets and has a reputation for being a patient and value-oriented investor. The company's primary focus is on creating long-term value for its shareholders by actively managing and growing its portfolio of investments. EXOR's core mission is to cultivate exceptional enterprises, simultaneously nurturing opportunities for its talented workforce to flourish, make meaningful societal contributions, and yield outstanding returns for its valued investors.
EXOR N.V. Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alim Shaikh
Investor
|
|||
Arnaud Sahuguet
Venture Partner at EXOR Seeds
|
|||
Benoît RIBADEAU-DUMAS
Partner
|
|||
Enrico Vellano
CFO
|
|||
John Elkann
CEO
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Noam Ohana invest in?
Noam Ohana invests primarily in Software, Transportation and Health Care startups, most often at Seed and Series A stage. Most of the 36 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Noam Ohana?
Public channels for Noam Ohana include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Noam Ohana last invest?
The most recent investment recorded for Noam Ohana closed in Feb 2026. Shizune tracks 36 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
